<p><em>Expert Perspectives</em><em><i>®</i></em> delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. <em>Expert Perspectives</em><em><i>®</i></em><em> in Advanced ROS1-Positive NSCLC</em> will feature community-selected experts and topics that we hope you will find of value in your clinical practice.</p>

---

VIEW THE TOPICS

<br>

Expert Roundtables

• Next-Generation Tyrosine Kinase Inhibitors for N0n–Small Cell Lung Cancer: Broadening the Therapeutic Arsenal, With a Focus on ROS1
• Optimizing Molecular Testing to Identify Drivers in Advanced N0n–Small Cell Lung Cancer, ROS1 Focus
• Treatment Advances in ROS1-Positive N0n–Small Cell Lung Cancer

<br>

Clinical Topic Updates

• Management of Central Nervous System Metastases in Patients With ROS1-Positive N0n–Small Cell Lung Cancer
• Molecular Testing in N0n–Small Cell Lung Cancer: Detecting Complex Rearrangements
• The Biology and Clinical Course of Advanced ROS1-Positive N0n–Small Cell Lung Cancer

<br>

Patient Care Perspectives

• From Mutation to Decision: Supporting N0n–Small Cell Lung Cancer Patients in Personalized Care Choices
• Integrated, Multidisciplinary Care to Support the Whole Person With Advanced N0n–Small Cell Lung Cancer
• Tyrosine Kinase Inhibitor Strategies for Intracranial Efficacy, Cognitive Safety in Advanced N0n–Small Cell Lung Cancer